Hyperhomocysteinemia but Not the C677T Mutation of Methylenetetrahydrofolate Reductase Is an Independent Risk Determinant of Carotid Wall Thickening
- 11 May 1999
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 99 (18) , 2383-2388
- https://doi.org/10.1161/01.cir.99.18.2383
Abstract
Background —Hyperhomocysteinemia has been identified as a potential risk factor for atherosclerosis. This study examined whether a modest elevation of plasma total homocysteine (tHcy) was an independent risk factor for increased carotid artery intimal-medial wall thickness (IMT) and focal plaque formation in a large, randomly selected community population. We also examined whether vitamin cofactors and the C677T genetic mutation of the methylenetetrahydrofolate reductase ( MTHFR ) enzyme were major contributors to elevated plasma tHcy and carotid vascular disease. Methods and Results —In 1111 subjects (558 men, 553 women) 52±13 years old (mean±SD; range, 27 to 77 years) recruited from a random electoral roll survey, we measured fasting tHcy and performed bilateral carotid B-mode ultrasound. For the total population, mean tHcy was 12.1±4.0 μmol/L. Plasma tHcy levels were correlated with IMT (Spearman rank r s =0.31, P =0.0001). After adjustment for age, sex, and other conventional risk factors, subjects in the highest versus the lowest quartile of tHcy had an odds ratio of 2.60 (95% CI, 1.51 to 4.45) for increased IMT and 1.76 (95% CI, 1.10 to 2.82) for plaque. Serum and dietary folate levels and the C677T mutation in MTHFR were independent determinants of tHcy (all P =0.0001). The mutant homozygotes (10% of the population) had higher mean tHcy than heterozygotes or those without the mutation (14.2 versus 12.3 versus 11.6 μmol/L, respectively, P =0.0001). The inverse association of folate levels with tHcy was steeper in the mutant homozygotes. Despite this, the C677T MTHFR mutation was not independently predictive of increased carotid IMT or plaque formation. Conclusions —Mild hyperhomocysteinemia is an independent risk factor for increased carotid artery wall thickness and plaque formation in a general population. Lower levels of dietary folate intake and the C677T mutation in MTHFR are important causes of mild hyperhomocysteinemia and may therefore contribute to vascular disease in the community.Keywords
This publication has 19 references indexed in Scilit:
- Biological Variability and Reference Intervals for Total Plasma HomocysteineAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1999
- The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemiaQJM: An International Journal of Medicine, 1996
- Homocysteine and vascular diseaseNature Medicine, 1996
- A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery StenosisNew England Journal of Medicine, 1995
- Homocysteine and cysteine: determinants of plasma levels in middle‐aged and elderly subjectsJournal of Internal Medicine, 1994
- Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly PopulationJAMA, 1993
- Measurement of intima-media thickness of common carotid arteries with high-resolution B-mode ultrasonography: Inter- and intra-observer variabilityUltrasound in Medicine & Biology, 1991
- A COMPUTERISED DIETARY ANALYSIS SYSTEM FOR USE WITH DIET DIARIES OR FOOD FREQUENCY QUESTIONNAIRESCommunity Health Studies, 1984